Initial efficacy of anti-lymphocyte activation gene-3 (anti–LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti–PD-1/PD-L1 therapy
article
Author/s
author: Paolo Antonio Ascierto, Ignacio Melero, MD-PhD, Thomas F. Gajewski, F Stephen Hodi, Petri Bono, Rachel E Sanborn, Yoshinobu Koguchi, Satyendra Suryawanshi, Shailender Bhatia, Evan J Lipson, Raphael Clynes, Priyam Mitra, Marta Nyakas
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.